73604-914Level 3
Arcalyst (rilonacept)
**Product type:** Human Prescription Drug
**Active ingredient:** RILONACEPT
**Strength:** 160 mg/2mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Subcutaneous
**Labeler:** Kiniksa Pharmaceuticals (UK), Ltd.
**Marketing category:** BLA (BLA125249)
GET
/api/v1/systems/ndc_fda/nodes/73604-914Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.